Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
celgene
life sciences
national blog main
new york
new york blog main
new york top stories
2
×
acceleron pharma
amgen
anemia
bcma
beta-thalassemia
bluebird bio
boston blog main
boston top stories
bristol-myers squibb
clinical trials fda
giovanni caforio
glaxosmithkline
idecabtagene vicleucel
johnson & johnson
lisocabtagene maraleucel
luspatercept
multiple myeloma
multiple sclerosis
myelodysplastic syndrome
myelofibrosis
national top stories
nick leschly
novartis
ozanimod
poseida therapeutics
rare diseases
What
approval
2
×
cell
2
×
drug
fda
acceleron
anemia
asks
bcma
bid
blood
bristol
celgene
declined
delay
detour
developed
disorder
experimental
hit
info
levels
low
multiple
myeloma
myers
patients
pharma
rare
red
refuses
regulatory
review
squibb’s
therapy
treat
win
wins
Language
unset
Current search:
approval
×
" new york top stories "
×
cell
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}